Modernizing Biopharmaceutical Sampling
Published July 31, 2014
Bend Research and pharmaceutical company partners are currently beta testing MAST, a modular automated sampling technology platform designed to allow for hands-off and contamination-free sampling from up to 8 bioreactors at a time. The platform has also been designed to enable at-line analysis, automated scheduling and other benefits. For more information, click here.
blog comments powered by Disqus